[Skip to Content]
[Skip to Content Landing]
February 14, 1925

Sero-, Vaccine- und Proteinkörpertherapie.

JAMA. 1925;84(7):540. doi:10.1001/jama.1925.02660330060041

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The author seems to proceed on the assumption that practicing physicians are to take all serums, vaccines and various forms of protein therapy pretty much at their label or face value. Thus, he says about antipneumococcus serum (p. 31), "We use it in all diseases that are caused by Pneumococcus lanceolatus, such as pneumonia or consecutive pericarditis, pleuritis, meningitis and ulcus serpens. The earliest possible use is indicated." This reminds one of commercial advertising. The book is one of a series on various medical topics issued with the cooperation of members of the Vienna medical faculty, but nevertheless it is superficial, anachronistic and worthless.

First Page Preview View Large
First page PDF preview
First page PDF preview